These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 22057972)
1. High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas. Iyevleva AG; Kuligina ESh; Mitiushkina NV; Togo AV; Miki Y; Imyanitov EN Breast Cancer Res Treat; 2012 Feb; 131(3):1049-59. PubMed ID: 22057972 [TBL] [Abstract][Full Text] [Related]
2. Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas. Imyanitov EN; Suspitsin EN; Grigoriev MY; Togo AV; Kuligina ESh; Belogubova EV; Pozharisski KM; Turkevich EA; Rodriquez C; Cornelisse CJ; Hanson KP; Theillet C Int J Cancer; 2002 Aug; 100(5):557-64. PubMed ID: 12124805 [TBL] [Abstract][Full Text] [Related]
3. Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias. Suspitsin EN; Sokolenko AP; Togo AV; Lazareva YR; Turkevich EA; Matsko DE; Henrich KO; Borresen-Dale AL; Schwab M; Cornelisse CJ; Imyanitov EN Int J Cancer; 2007 Jan; 120(2):297-302. PubMed ID: 17066426 [TBL] [Abstract][Full Text] [Related]
4. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056 [TBL] [Abstract][Full Text] [Related]
5. Different methylation and microRNA expression pattern in male and female familial breast cancer. Pinto R; Pilato B; Ottini L; Lambo R; Simone G; Paradiso A; Tommasi S J Cell Physiol; 2013 Jun; 228(6):1264-9. PubMed ID: 23160909 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Bockmeyer CL; Christgen M; Müller M; Fischer S; Ahrens P; Länger F; Kreipe H; Lehmann U Breast Cancer Res Treat; 2011 Dec; 130(3):735-45. PubMed ID: 21409395 [TBL] [Abstract][Full Text] [Related]
7. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017 [TBL] [Abstract][Full Text] [Related]
8. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. Ota D; Mimori K; Yokobori T; Iwatsuki M; Kataoka A; Masuda N; Ishii H; Ohno S; Mori M Int J Oncol; 2011 Apr; 38(4):955-62. PubMed ID: 21271219 [TBL] [Abstract][Full Text] [Related]
9. High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. Rask L; Balslev E; Jørgensen S; Eriksen J; Flyger H; Møller S; Høgdall E; Litman T; Nielsen BS APMIS; 2011 Oct; 119(10):663-73. PubMed ID: 21917003 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646 [TBL] [Abstract][Full Text] [Related]
11. The role of p53 mutations in bilateral breast carcinoma. Ackerman J; Baunoch DA; Gimotty P; George J; Lane MA; Dawson PJ Mod Pathol; 1995 Apr; 8(3):244-8. PubMed ID: 7617647 [TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of bilateral breast cancer. Imyanitov EN; Hanson KP Cancer Lett; 2003 Feb; 191(1):1-7. PubMed ID: 12609703 [TBL] [Abstract][Full Text] [Related]
14. Bilateral breast carcinoma: clinical characteristics and its impact on survival. Vuoto HD; García AM; Candás GB; Zimmermann AG; Uriburu JL; Isetta JA; Cogorno L; Khoury M; Bernabó OL Breast J; 2010; 16(6):625-32. PubMed ID: 21070440 [TBL] [Abstract][Full Text] [Related]
15. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability analysis of bilateral breast tumors suggests treatment-related origin of some contralateral malignancies. Kuligina ESh; Grigoriev MY; Suspitsin EN; Buslov KG; Zaitseva OA; Yatsuk OS; Lazareva YR; Togo AV; Imyanitov EN J Cancer Res Clin Oncol; 2007 Jan; 133(1):57-64. PubMed ID: 16900353 [TBL] [Abstract][Full Text] [Related]
17. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Leite KR; Sousa-Canavez JM; Reis ST; Tomiyama AH; Camara-Lopes LH; Sañudo A; Antunes AA; Srougi M Urol Oncol; 2011; 29(3):265-9. PubMed ID: 19372056 [TBL] [Abstract][Full Text] [Related]
18. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Leskelä S; Leandro-García LJ; Mendiola M; Barriuso J; Inglada-Pérez L; Muñoz I; Martínez-Delgado B; Redondo A; de Santiago J; Robledo M; Hardisson D; Rodríguez-Antona C Endocr Relat Cancer; 2011 Feb; 18(1):85-95. PubMed ID: 21051560 [TBL] [Abstract][Full Text] [Related]
19. Obesity impacts the regulation of miR-10b and its targets in primary breast tumors. Meerson A; Eliraz Y; Yehuda H; Knight B; Crundwell M; Ferguson D; Lee BP; Harries LW BMC Cancer; 2019 Jan; 19(1):86. PubMed ID: 30658617 [TBL] [Abstract][Full Text] [Related]
20. Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping. Tse GM; Kung FY; Chan AB; Law BK; Chang AR; Lo KW Am J Clin Pathol; 2003 Aug; 120(2):168-74. PubMed ID: 12931545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]